CBD of Denver Stock Forecast & Price Prediction 2026-2027
Algorithmic price targets and analysis for CBDD based on fundamentals, valuation multiples, and historical data.
Price Target Summary
Technical Outlook
52-Week Range Analysis
Fundamental Analysis
Revenue Growth Projection
Based on +41.8% YoY growth, tapered 20% per year in outer projections.
Valuation vs Peers
Cash Position
Key Metrics
| Current Price | $43.74 |
| Market Cap | $3.21B |
| P/S Ratio | 6.69x |
| Revenue (TTM) | $1.22B |
| Revenue Growth (YoY) | +41.8% |
| Gross Margin | 2.1% |
| Cash on Hand | $264.3M |
| Total Debt | $536.0M |
| 52W High | $54.17 |
| 52W Low | $26.05 |
Signal Breakdown
- Strong revenue growth above 10% YoY
- Healthy gross margins above 40%
- Total debt exceeds cash position
- Trading near 52-week highs
- Elevated P/S ratio relative to sector
Risk Factors
- High debt-to-cash ratio: total debt of $536.0M significantly exceeds cash of $264.3M.
- Share dilution rate of 17.2% is above average, which may erode shareholder value.
Analyst Summary
CBD of Denver (CBDD) is a CBD cannabis company with rapidly growing revenue and a market capitalization of $3.21B. Based on trailing revenue of $1.22B and a P/S ratio of 6.69x, the stock trades at a premium relative to the sector median of 2.5x. Our algorithmic base-case price target of $58.85 implies upside of 34.5% from current levels. The overall signal is bullish, supported by positive fundamental indicators. Investors should weigh the 2 identified risk factors before making any investment decision.
Frequently Asked Questions
What is the price target for CBDD?+
Is CBDD a buy right now?+
What is the revenue forecast for CBD of Denver?+
What are the risks of investing in CBDD?+
How does CBDD valuation compare to the cannabis sector?+
Important Disclaimer
This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.